ALLUVI BPC-157 & TB-500 Pre-Filled Pen (40mg) – Dual-Action Recovery Research Compound

£124.99

+ Free Shipping

The Alluvi BPC-157 & TB-500 Pre-Filled Pen (40mg) is a high-purity, ready-to-use research peptide device developed by Alluvi Healthcare. Engineered specifically for laboratory recovery, tissue repair, and angiogenic pathway research, this dual-action compound delivers a total of 40mg (4 x 10mg dosing) in a stabilized liquid format—eliminating the need for manual reconstitution.

Guaranteed Safe Checkout

The Alluvi BPC-157 & TB-500 40mg Pen is a precision-formulated investigational peptide device developed for laboratory repair and tissue recovery research applications. Developed by Alluvi Healthcare, this prefilled pen contains a synchronized 40mg dual-peptide blend engineered for cellular repair, angiogenic, and anti-inflammatory pathway studies.

Each pen delivers a total peptide content of 40mg in a stabilized solution format designed for controlled and repeatable research administration. The convenient pen system removes the need for reconstitution while supporting accurate, unit-dial dose selection.  Alluvi BPC-157 & TB-500

Key Features

  • 40mg total peptide content (dual-action BPC-157 & TB-500 research blend)

  • Dual-action recovery compound for advanced cellular research

  • Engineered for angiogenesis, tissue repair, and inflammatory modulation pathways

  • Prefilled research pen with 4 x 10mg dosing format

  • No reconstitution required – pre-mixed, stabilized solution

  • Precision dosing delivery system for consistent measurement

  • Manufactured to high purity standards by Alluvi Healthcare

How to Use

  • Attach a sterile compatible needle before use

  • Prime according to package instructions if required

  • Select the desired dose for research protocol

  • Administer via subcutaneous route where applicable

  • Store refrigerated between 2–8°C

How It Works

  • BPC-157 and TB-500 act synergistically to target cellular repair, angiogenesis, and tissue migration mechanisms.

  • Research focuses on collagen synthesis, extracellular matrix remodeling, and systemic anti-inflammatory pathways.

  • The Alluvi prefilled pen format supports convenient laboratory administration without reconstitution variability.

  • Precision dial dosing allows controlled, accurate, and repeatable investigational outcomes.

Recommended Research Pairings

  • May complement broader tissue regeneration and recovery investigation protocols.

  • Often researched alongside Alluvi Retatrutide or metabolic frameworks for comprehensive systemic studies.

  • Can be included within advanced multi-variable laboratory peptide studies.

Reviews

There are no reviews yet.

Be the first to review “ALLUVI BPC-157 & TB-500 Pre-Filled Pen (40mg) – Dual-Action Recovery Research Compound”

Your email address will not be published. Required fields are marked *